Senior Director, Patient Marketing (US, Rare Disease)

Alfasigma is a privately held global healthcare company founded over 75 years ago in Italy, where it remains headquartered today in Bologna and Milan. The Group operates in over 100 markets spanning Europe, North and South America, Asia, and Africa. Over three years ago, we embarked on a transformative journey to become a truly global innovative healthcare company with a leading focus on Gastrointestinal (GI) health. We have experienced remarkable growth, nearly doubled our revenues, expanding geographically, and integrating several key acquisitions. We have also evolved our portfolio, expanded into rare and specialty segments, and strengthened our pipeline and people's capabilities. But our journey is far from complete! In fact, this is just the beginning of a bold new chapter in Alfasigma's history. We are committed to advancing innovation and leveraging our deep expertise to provide better health and a better quality of life for patients and consumers worldwide and expand our reach across diverse markets. As we continue to grow, we are seeking a Senior Director, Patient Marketing, to join the US Pharmaceuticals team. The Senior Director of Patient Marketing will report to the Vice President, Head of Marketing US, and will lead the strategy and execution of patient marketing to support the successful US launch of LYNAVOY. This role is accountable for delivering a patient-first, compliant engagement approach across unbranded disease education, branded patient education and initiatives, and post launch support programs that enable awareness, activation, and persistence. The Senior Director will work cross-functionally with Patient Advocacy, HCP Marketing, Omnichannel Marketing, Medical Affairs, Patient Services, Regulatory, Analytics, and Compliance to ensure a cohesive and high-quality patient experience across pre-launch, launch, and early post-launch phases, consistent with Alfasigma’s values and commitment to ethical, patient-focused results.